Search results
vWF Deficient Plasma
For any in vitro protocol or research study where a source of vWF deficient plasma is required.
Protein S Deficient Plasma
For any in vitro protocol or research study where a source of human protein S deficient plasma is required.
BIOPHEN Antithrombin (anti-IIa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
BIOPHEN Antithrombin LRT (anti-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
Plasminogen, Human
Recommended for any research study on fibrinolysis.
(h)PT-Phen (PT reagent, recombinant)
Determination of prothrombin time (PT) in human citrated plasma.
(h)PT-Phen (PT reagent, recombinant)
Determination of prothrombin time (PT) in human citrated plasma.
FIBRIPHEN 5
Measurement of fibrinogen in plasma. Detection of low fibrinogen concentrations. Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation Risk factor for cardiovascular disease and thrombosis Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis). Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.
Antithrombin, Human
Recommended for any study on heparin and glyco-amino-glycans. Useful for designing heparin assays (clotting or chromogenic) where a source of AT is required.
Antithrombin, Human
Recommended for any study on heparin and glyco-amino-glycans. Useful for designing heparin assays (clotting or chromogenic) where a source of AT is required.